CNBX Pharmaceuticals enters convertible note with $55K initial, up to $850K, 35% discount conversion

CNBX Pharmaceuticals Inc.

Issue Date Jan 23, 2025; maturity Oct 30, 2025; 10% interest, 9% OID, default interest 22%.
Conversion price at 65% of market price (35% discount), exercisable from day 180.
Company may prepay at 110%-130% of face during first 180 days; later subject to holder agreement.
Company must register all shares; holder prohibited from short-selling during term.
Institutional investor 1800 Diagonal Lending LLC provided $55,000, with potential up to $850,000.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.